免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

科尼索爾

K 號:K221759 · 2022-10-05

申請人Aurolab
決定日期2022-10-05
產品代碼LYX
決定相當於

器材摘要

Cornisol is the device name listed in this FDA 510(k) record. The listed applicant is Aurolab. It received FDA 510(k) clearance on 2022-10-05 under 510(k) number K221759. The device is classified under product code LYX. FDA Decision: Substantially Equivalent.

常見問題

What is the Cornisol?

Cornisol is a medical device that received FDA 510(k) clearance on 2022-10-05. The listed applicant is Aurolab. The 510(k) number is K221759.

When did Cornisol receive FDA 510(k) clearance?

Cornisol received FDA 510(k) clearance on 2022-10-05, under 510(k) number K221759.

Who is the listed applicant for Cornisol?

The FDA 510(k) record lists Aurolab as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Cornisol?

The FDA product code for Cornisol is LYX.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:LYX)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑